Evidence map›Paper›PMID 33452637›Full record

ArticleJournal of fluorescence2021

Investigation of Gd

Muktesh Mohan, Raju Poddar

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of fluorescence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Muktesh MohanBiophotonics Lab, Department of Bioengineering, Birla Institute of Technology-Mesra, Ranchi, JH, 835215, India.
Raju PoddarBiophotonics Lab, Department of Bioengineering, Birla Institute of Technology-Mesra, Ranchi, JH, 835215, India. rpoddar@bitmesra.ac.in.ORCID http://orcid.org/0000-0001-6945-9555
Birla Institute of Technology, Mesra · IN

Funding

Indian Council of Medical Research 5/2021 (Bio)/2014-ITR-1Science and Engineering Research Board EMR/2015/001757
6 · The paper itself

Abstract

Currently, upconversion nanoparticles (UCNPs) implanted as a contrast agent for optical coherence tomography (OCT) system due to its biocompatibility, anti-stock emission, narrow emission bandwidth non-photobleaching effects etc., but it was not used as multi model imaging probe. We synthesized multimodal imaging probe having upconversion property along with paramagnetic property and used as dual contrast agents for Photothermal Optical Coherence Tomography (PTOCT) and Magnetomotive Optical Coherence Tomography (MMOCT). The synthesized Gd

Indexed as

Tomography, Optical CoherenceAlgorithmsCells, CulturedContrast MediaErbiumGadoliniumHumansNanoparticlesYtterbiumContrast MediaErbiumGadoliniumgadolinium oxideYtterbiumBiomedical imagingContrast agentMagnetomotive optical coherence tomographyPhotothermal optical coherence tomographySwept source optical coherence tomographyUpconversion nanoparticles

Identifiers

PMID33452637
OpenAlexW3121162402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.